Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PEAK HEALTH AND WELLNESS, LLC

NPI: 1528460482 · FARR WEST, UT 84404 · Clinical Medical Laboratory · NPI assigned 09/23/2014

$423K
Total Medicaid Paid
17,687
Total Claims
12,706
Beneficiaries
12
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHAINSWORTH, BRYAN (PRESIDENT)
NPI Enumeration Date09/23/2014

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 1,623 $49K
2019 399 $22K
2023 9,136 $136K
2024 6,529 $216K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 4,961 3,622 $219K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 3,054 2,166 $152K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,738 1,309 $19K
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 124 106 $17K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 2,001 1,296 $7K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 686 442 $6K
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 1,630 1,179 $1K
J1885 Injection, ketorolac tromethamine, per 15 mg 1,481 1,092 $601.14
J3475 Injection, magnesium sulfate, per 500 mg 1,629 1,181 $492.67
83986 127 104 $0.00
83992 129 105 $0.00
82570 127 104 $0.00